# Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

> **NCT03395587** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 136 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **BIOLOGICAL:** Autologous, tumor lysate-loaded, mature dendritic cells (DC)
- **DRUG:** standard therapy

## Key facts

- **NCT ID:** NCT03395587
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-03-06
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2024-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03395587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03395587, "Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03395587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*